WeChat Mini Program
Old Version Features

A Very Early Clinical Response to Treatment with the Janus Kinase Inhibitor Tofacitinib in Patients with Active Rheumatoid Arthritis: the Dynamics of Pain and Central Sensitization Elements

Современная ревматология(2020)

Cited 2|Views2
Key words
rheumatoid arthritis,chronic pain,central sensitization,tofacitinib,efficacy,safety
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined